No. (%) | |||
---|---|---|---|
Variables | MSSA n = 89 | MRSA n = 110 | P |
Age | |||
0–3 mo | 11 (12.4) | 7 (6.4) | |
4–59 mo | 42 (47.2) | 82 (74.5) | < 0.01 |
5–10 y | 12 (13.5) | 10 (9.1) | |
11–18 y | 24 (26.9) | 11 (10.0) | |
Gender | |||
Male | 46 (51.7) | 47 (42.7) | 0.25 |
Female | 43 (48.3) | 63 (57.3) | |
Clinical manifestations | |||
Skin and soft tissue infections | 47 (52.8) | 85 (77.3) | < 0.01 |
Invasive infections | 42 (47.2) | 25 (22.7) | |
Healthcare-associated risk factors | |||
Present | 31 (34.8) | 33 (30.0) | 0.57 |
Absent | 58 (65.2) | 77 (79.0) |